ORKA
Oruka Therapeutics, Inc.Healthcare$53.31
▼ Bearish
Mkt Cap: $2.64B|Float: 35.1M|SI: 10.4%|DTC: 9.1
Data as of market close Apr 2, 2026
IV Rank
93
IV Pctl
78%
HV 20d
101.7%
52W Range
$5-$54
ATR(14)
$3.24
Exp. Move
±6.6%
P/C Ratio
2.12
Earnings
May 13
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
ORKA Key Options Data
- IV Rank
- 92.5%
- Total GEX
- $-0.00B
- Total DEX
- $0.0M
- Max Pain
- $40.00
- Expected Move
- ±6.6%
- Put/Call OI
- 2.12
- Net Premium
- $0.5M
- Spot Price
- $53.31
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.50 | ±6.6% | $49.81 | $56.81 |
| 2026-05-15 | 43 | ±$8.75 | ±16.4% | $44.56 | $62.06 |
| 2026-08-21 | 141 | ±$40.15 | ±75.3% | $13.16 | $93.46 |
| 2026-11-20 | 232 | ±$23.95 | ±44.9% | $29.36 | $77.26 |
| 2026-12-18 | 260 | ±$23.25 | ±43.6% | $30.06 | $76.56 |
Explore ORKA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.